Is Molina Healthcare (MOH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina (MOH) Soars 6.3%: Is Further Upside Left in the Stock?
Molina (MOH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Is Molina Healthcare (MOH) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Molina Healthcare (MOH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Molina Healthcare Worth Buying at a Premium 26.83X P/E Valuation?
MOH's premium valuation reflects confidence in growth, acquisitions and cash strength, even as elevated medical costs pressure margins.
Molina (MOH) Up 3.8% Since Last Earnings Report: Can It Continue?
Molina (MOH) reported earnings 30 days ago. What's next for the stock?
Here's Why Molina (MOH) Could be Great Choice for a Bottom Fisher
Molina (MOH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Are Investors Undervaluing Molina Healthcare (MOH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare, Inc. (MOH) Analyst/Investor Day Transcript
Molina Healthcare, Inc. (MOH) Analyst/Investor Day Transcript
Molina: Q1 Beat Proves The Cost Story, Now Comes Hard Decision For The Management
Molina Healthcare (MOH) remains rated Hold as clarity on post-MAPD cost structure and market share recovery is still pending. MOH's exit from Medicare Advantage removes $1B in unprofitable revenue, improving business quality but shrinking the top line. 2026 guidance is reaffirmed at $42B premium revenue and at least $5.00 adjusted EPS, with underlying normalized earnings power closer to $7.50 per share.
MOH Q1 EPS Tops Estimates on Lower Medical Costs, Membership Declines
Molina Healthcare beats Q1 EPS estimates, but profits plunge 61% as revenues dip, membership shrinks and premiums decline despite lower medical costs support.
Molina Healthcare, Inc. (MOH) Q1 2026 Earnings Call Transcript
Molina Healthcare, Inc. (MOH) Q1 2026 Earnings Call Transcript
